Lichen sclerosus does not directly cause yeast infections, but the two conditions are deeply tangled in ways that matter for anyone dealing with either one. The steroid creams used to treat lichen sclerosus can trigger yeast overgrowth as a side effect, and the conditions share enough symptoms that nearly half of premenopausal women with lichen sclerosus are initially told they have a yeast infection instead. That overlap creates real confusion and real delays in getting the right treatment.
The Misdiagnosis Problem
The single most important thing to understand about lichen sclerosus and yeast infections is how often one is mistaken for the other. In a cross-sectional study of premenopausal women with lichen sclerosus, two out of three had initially received a different diagnosis altogether, and the most common wrong diagnosis was vulvovaginal yeast infection, affecting about half the group. On average, those women experienced a four-year gap between when symptoms started (around age 27) and when they finally received the correct lichen sclerosus diagnosis (around age 32).1Journal of Lower Genital Tract Disease. Presenting Symptoms and Diagnosis of Vulvar Lichen Sclerosus in Premenopausal Women: A Cross-Sectional Study
This happens because the symptoms overlap more than you would expect. Both conditions can cause intense vulvar itching, soreness, and irritation. Redness and changes to the skin surface can look similar on a quick exam. When a younger woman walks into a clinic with vulvar itch, yeast infection is the most common diagnosis clinicians reach for because it is so much more prevalent in that age group. Lichen sclerosus tends to be associated with postmenopausal women, so the pattern-matching instinct in many providers steers them away from it in younger patients.
Four years of being treated for the wrong condition is not a trivial inconvenience. Lichen sclerosus that goes untreated can cause progressive scarring, narrowing of the vaginal opening, and long-term changes to the vulvar architecture. In rare cases it is associated with vulvar cancer. Getting the diagnosis right early changes the trajectory of the disease substantially.
How Steroid Treatment Can Trigger Yeast
Once lichen sclerosus is correctly diagnosed, the standard treatment involves potent topical corticosteroids, typically clobetasol propionate. These creams are effective at calming the inflammation and slowing the scarring process. But they come with a well-documented side effect: they suppress the local immune response, which can let Candida (the fungus behind most yeast infections) get a foothold.
In a study of premenarchal girls treated with clobetasol for vulvar lichen sclerosus, one patient developed a yeast superinfection during treatment.2Obstetrics & Gynecology. Clobetasol propionate in the treatment of premenarchal vulvar lichen sclerosus This is a recognized complication of topical steroid use on genital skin, not unique to lichen sclerosus. The genital area is warm, moist, and already home to small numbers of Candida organisms. Apply a potent immunosuppressive cream and you remove one of the checks that keeps those organisms from multiplying out of control.
So while lichen sclerosus itself does not breed yeast, the treatment for it can. If you are using a strong steroid cream and develop new symptoms like a thick white discharge, worsening itch that feels different from your baseline, or burning during urination, it is worth flagging the possibility of a secondary yeast infection with your provider rather than assuming the lichen sclerosus is simply getting worse.
When Treatment Stops Working
A secondary yeast infection also matters in the context of lichen sclerosus that seems to stop responding to treatment. Clinical guidance notes that when a patient with lichen sclerosus fails to improve on appropriate therapy, the cause may be an incorrect initial diagnosis, a secondary problem such as allergic contact dermatitis or a bacterial or fungal infection, or in more serious cases, the development of precancerous or cancerous changes.3PubMed Central. Lichen sclerosus: a potpourri of misdiagnosed cases based on atypical clinical presentations
The practical takeaway: if your lichen sclerosus symptoms flare despite consistent treatment, do not just increase the steroid strength or assume things are progressing. A fungal infection riding along on top of the lichen sclerosus can mimic a flare, and the treatment for one (more steroids) will make the other (yeast) worse. A simple swab culture or clinical evaluation can sort this out and avoid a frustrating cycle of worsening symptoms.
What Microbiome Research Actually Shows
Researchers have started looking at the microbial communities living on vulvar skin affected by lichen sclerosus, and the findings add useful nuance. A study that sequenced the microbiome of vulvar lichen sclerosus lesions found that while bacteria and viruses were the most abundant organisms, fungal species were scarcely observed.4PubMed Central. The vulvar microbiome in lichen sclerosus and high-grade intraepithelial lesions In other words, the lichen sclerosus skin itself does not appear to be crawling with Candida. The disease does not seem to create a fungal paradise on its own.
That said, the picture is not entirely clean. A separate study using both bacterial and fungal sequencing techniques found that lichen sclerosus in postmenopausal women was associated with alterations in both the bacterial and fungal microbiome, alongside changes in local hormone levels.5PubMed. Assessment of the Cutaneous Hormone Landscapes and Microbiomes in Vulvar Lichen Sclerosus The word “alterations” is doing a lot of work there. It means the fungal community was different in disease versus health, but not necessarily that it was growing out of control in a way that would produce clinical symptoms of a yeast infection. The research is still early, and what counts as a meaningful shift in the vulvar mycobiome is not yet well defined.
The honest read of the microbiome evidence right now is that lichen sclerosus changes the microbial landscape in some way, but the changes are primarily bacterial, and fungal overgrowth does not appear to be a hallmark of the disease itself. When yeast does become a problem, the steroid treatment is the more likely culprit than the disease.
The Immune Paradox in Lichen Sclerosus Skin
You might assume that because lichen sclerosus involves chronic inflammation, the affected skin would be less capable of fighting off infections like Candida. The reality is more counterintuitive. Research has found that lichen sclerosus lesions actually produce elevated levels of certain antimicrobial peptides, proteins the skin uses to fight off microbes. Specifically, levels of hBD-2 and psoriasin, two key defense molecules, were substantially higher in lichen sclerosus tissue compared to healthy skin.6British Journal of Dermatology. Significant upregulation of antimicrobial peptides and proteins in lichen sclerosus
Psoriasin in particular has known antifungal activity. So the inflamed skin in lichen sclerosus may actually be ramping up its defenses rather than letting them down. This fits with the microbiome data showing sparse fungal colonization on lichen sclerosus lesions. The immune system is not asleep at the wheel; if anything, it is in overdrive. But this is the immune system attacking the body’s own tissue (lichen sclerosus is considered autoimmune in nature), so “more immune activity” does not translate to “healthier skin.” It means the skin is inflamed, scarring, and fighting on multiple fronts simultaneously.
The practical implication is that lichen sclerosus alone probably keeps yeast at bay reasonably well. The vulnerability to yeast comes primarily when you layer on topical steroids, which suppress exactly the kind of local immune activity those antimicrobial peptides represent.
Skin Barrier Changes and Vulnerability
Lichen sclerosus thins and weakens the skin over time. In postmenopausal women, this compounds the effects of declining estrogen, which already compromises the skin barrier’s defenses and increases susceptibility to microbial colonization and mechanical injury.7Clinical Obstetrics and Gynecology. Unique Dermatologic Aspects of the Postmenopausal Vulva – Section: Abstract The combination of thinning skin, reduced estrogen, and blunted cell-mediated immune responses creates conditions where secondary infections of various kinds, including yeast, are theoretically more likely to take hold.
This is worth understanding because it means the risk profile shifts with age and hormonal status. A premenopausal woman with lichen sclerosus has a different set of vulnerabilities than a postmenopausal woman with the same condition. For postmenopausal women, maintaining the skin barrier through gentle care, avoiding irritants, and using emollients on affected skin becomes especially important. Any break in the already compromised skin surface is an invitation for opportunistic organisms.
The Same Confusion Happens in Men
Lichen sclerosus is not exclusively a condition affecting women, though it is more commonly discussed in that context. Men can develop lichen sclerosus on the foreskin and glans of the penis, where it was historically called balanitis xerotica obliterans. And the same diagnostic confusion occurs: a systematic review found that male genital lichen sclerosus is frequently misreported as candidal (yeast) balanitides or other infections.8PubMed. Male genital lichen sclerosus misreported as candidal or other infective balanitides: A systematic review of the literature Even when biopsies were performed in these cases, histological confirmation was frequently non-specific, meaning the tissue samples did not always point clearly to one diagnosis or the other.
For men, the consequences of misdiagnosis are different but still significant. Untreated lichen sclerosus on the foreskin can lead to phimosis (tightening that makes the foreskin difficult to retract), urinary difficulties, and in some cases, the same cancer risk seen in vulvar lichen sclerosus. Repeated courses of antifungal cream for what is actually lichen sclerosus delays effective treatment and allows scarring to progress.
How to Tell the Difference
Given how often these conditions are confused, knowing the distinguishing features can save you time and frustration. Yeast infections typically produce a thick, white, cottage cheese-like discharge and tend to come with burning during urination or sex. The itching is usually concentrated inside the vagina and around the vaginal opening. Symptoms often develop relatively quickly and respond to antifungal treatment within a week or two.
Lichen sclerosus, by contrast, tends to produce itching that is more diffuse across the vulvar skin. The hallmark visual sign is white, parchment-like patches of skin that may appear crinkled or thinned. There is usually no abnormal discharge. Over time, the skin changes become more visible: loss of the normal labial architecture, fusion of tissue, and fissures (small cracks) that bleed easily. The course is chronic and progressive rather than episodic.
The clearest red flag is a pattern of “yeast infections” that keep coming back despite treatment. If antifungal creams and oral fluconazole are not resolving your symptoms, or if they briefly improve things but the itch always returns, the underlying problem may not be yeast at all. That pattern should prompt a closer look, ideally with a biopsy, rather than another round of the same antifungal.
Sexual Function and Quality of Life
Researchers have directly compared the impact of lichen sclerosus and yeast infections on sexual health. In a study of over 300 women, those with biopsy-confirmed lichen sclerosus reported less frequent sexual activity than both healthy controls and women with vulvovaginal candidiasis. Among women who were sexually active, those with lichen sclerosus were less likely to have vaginal intercourse compared to either group, even though similar proportions of all three groups said vaginal intercourse was important to them.9PubMed Central. The Impact of Vulvar Lichen Sclerosus on Sexual Dysfunction
The difference matters because lichen sclerosus can cause structural changes to the vulva that make intercourse physically difficult or painful in ways that a yeast infection does not. Scarring and tissue fusion narrow the introitus (vaginal opening), and the thinned skin tears more easily. A yeast infection is uncomfortable and can certainly put sex on hold, but it resolves and does not leave permanent physical changes. The chronic and progressive nature of lichen sclerosus has a compounding effect on sexual function that is qualitatively different from the temporary disruption of a yeast infection.
This distinction reinforces why the diagnostic confusion between the two is not an academic problem. A woman treated for recurrent yeast infections for years while actually living with lichen sclerosus is not only getting the wrong medication; she may be accumulating irreversible tissue changes that affect her sexual health and anatomy in ways that a correct early diagnosis could have minimized.
Practical Steps If You Have Both Conditions
Having lichen sclerosus does not make you immune to getting a yeast infection through the usual routes. And as noted, steroid treatment can tip the scales toward Candida overgrowth. If you are managing lichen sclerosus and suspect a concurrent yeast infection, a few practical considerations apply:
- Get it confirmed: Do not assume itch equals yeast. Ask for a swab culture before treating, especially if your lichen sclerosus was recently in a stable phase and symptoms suddenly changed character.
- Communicate with your provider about steroid use: If yeast infections keep cropping up during steroid treatment, your provider may adjust the frequency or potency of the cream, or add a short course of antifungal alongside it.
- Avoid over-the-counter shotgun approaches: Combination creams that contain both antifungal and steroid ingredients are available, but using them without knowing what you are actually treating can mask symptoms and delay the right diagnosis in either direction.
- Protect the skin barrier: Fragrance-free emollients, loose cotton underwear, and gentle cleansing practices help maintain whatever barrier function remains in lichen sclerosus-affected skin and reduce the opportunity for secondary infections.
Why This Confusion Persists
Part of the reason the lichen sclerosus-yeast mix-up endures is structural. Yeast infections are extremely common, familiar to most clinicians, and often diagnosed based on symptoms alone without confirmatory testing. Lichen sclerosus, while not rare, is less common and less likely to be on a provider’s radar, especially in younger patients. The symptoms of both conditions can be nonspecific. And many women self-treat yeast infections with over-the-counter products before ever seeing a clinician, which means that by the time they do seek care, the clinical picture may be muddied by partial treatment effects.
Biopsy remains the gold standard for diagnosing lichen sclerosus. The characteristic histological pattern (thinning of the outer skin layer with a band of altered collagen beneath it) is distinctive when present, though as the male lichen sclerosus review noted, biopsies are not always conclusive and results can be non-specific. In clinical practice, experienced dermatologists and gynecologists can often make the diagnosis visually when the white, atrophic patches are well established. The challenge is the early and mild cases where the visual signs have not yet fully developed, which is exactly when misdiagnosis as yeast is most likely.
If there is one point worth remembering from all of this, it is that recurrent “yeast infections” that do not respond to antifungal treatment deserve a closer look. Lichen sclerosus is one of the conditions hiding behind that pattern, and early identification changes the long-term outlook substantially.